Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Pulmonary Hypertension

Free Subscription Articles published in J Heart Lung Transplant Retrieve available abstracts of 129 articles: HTML format

Single Articles

April 2024
1. BUNCLARK K, Toshner M
   Anthropometrics are important to consider in purported sex differences in CTEPH outcomes.
   J Heart Lung Transplant. 2024;43:688.
   PubMed    
   
   
   March 2024
2. BARBERA JA, Peinado VI, Blanco I
   UNTANGLING SEVERE PULMONARY HYPERTENSION IN COPD.
   J Heart Lung Transplant. 2024 Mar 22:S1053-2498(24)01538.
   PubMed    
   
   
   February 2024
3. ZEDER K, Marsh LM, Avian A, Brcic L, et al
   Compartment-specific remodeling patterns in end-stage chronic obstructive pulmonary disease with and without severe pulmonary hypertension.
   J Heart Lung Transplant. 2024 Feb 19:S1053-2498(24)01087.
   PubMed     Abstract available
   
   
   
4. RAKO ZA, Yogeswaran A, Yildiz S, Weidemann P, et al
   Liver stiffness is associated with right heart dysfunction, cardiohepatic syndrome, and prognosis in pulmonary hypertension.
   J Heart Lung Transplant. 2024 Feb 17:S1053-2498(24)00056.
   PubMed     Abstract available
   
   
   
5. DESJARDIN JT, Kime N, Kolaitis NA, Kronmal RA, et al
   Investigating the "sex paradox" in pulmonary arterial hypertension: results from the Pulmonary Hypertension Association Registry (PHAR).
   J Heart Lung Transplant. 2024 Feb 13:S1053-2498(24)00044.
   PubMed     Abstract available
   
   
   
6. MCLAUGHLIN V, Farber HW, Highland KB, Hemnes AR, et al
   Disease characteristics, treatments, and outcomes of patients with pulmonary arterial hypertension treated with selexipag in real-world settings from the SPHERE registry (SelexiPag: tHe usErs dRug rEgistry).
   J Heart Lung Transplant. 2024;43:272-283.
   PubMed     Abstract available
   
   
   
7. CHIA AXF, Valchanov K, Ng C, Tsui S, et al
   Perioperative extracorporeal membrane oxygenation support for pulmonary endarterectomy: A 17-year experience from the UK national cohort.
   J Heart Lung Transplant. 2024;43:241-250.
   PubMed     Abstract available
   
   
   January 2024
8. GHIO S, Corsico A, Rapagnani A, Borrelli E, et al
   Does pulmonary endarterectomy improve the clinical conditions of patients with chronic thromboembolic pulmonary disease without pulmonary hypertension?
   J Heart Lung Transplant. 2024 Jan 4:S1053-2498(23)02203.
   PubMed     Abstract available
   
   
   
9. JUTANT EM, Chelgham MK, Ottaviani M, Thuillet R, et al
   Central role of ubiquitin-specific protease 8 in leptin signaling pathway in pulmonary arterial hypertension.
   J Heart Lung Transplant. 2024;43:120-133.
   PubMed     Abstract available
   
   
   December 2023
10. PARIKH R, Farber HW
    Response to "Derivation and validation of a noninvasive prediction tool to identify pulmonary hypertension in patients with IPF: Evolution of the model FORD" by Nathan et al.
    J Heart Lung Transplant. 2023 Dec 27:S1053-2498(23)02199.
    PubMed    
    
    
    
11. JANOWSKI AM, Ravellette KS, Insel M, Garcia JG, et al
    Advanced Hemodynamic and Cluster Analysis for Identifying Novel RV function subphenotypes in Patients with Pulmonary Hypertension.
    J Heart Lung Transplant. 2023 Dec 21:S1053-2498(23)02178.
    PubMed     Abstract available
    
    
    
12. CRUZ-UTRILLA A, Lopez-Gude MJ, Velazquez M, Ynsaurriaga FA, et al
    Comment on the article titled "Impact of sex on outcome after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension" published by J. Chan et al.
    J Heart Lung Transplant. 2023 Dec 21:S1053-2498(23)02177.
    PubMed    
    
    
    
13. TAKANO R, Aoki T, Asano R, Ueda J, et al
    Recurrent Pulmonary Hypertension After Balloon Pulmonary Angioplasty for Inoperable Chronic Thromboembolic Pulmonary Hypertension.
    J Heart Lung Transplant. 2023 Dec 19:S1053-2498(23)02174.
    PubMed     Abstract available
    
    
    November 2023
14. KIANZAD A, Baccelli A, Braams NJ, Andersen S, et al
    Long-term effects of pulmonary endarterectomy on pulmonary hemodynamics, cardiac function and exercise capacity in chronic thromboembolic pulmonary hypertension.
    J Heart Lung Transplant. 2023 Nov 22:S1053-2498(23)02130.
    PubMed     Abstract available
    
    
    
15. NATHAN SD, Chandel A, Wang Y, Xu J, et al
    Derivation and validation of a non-invasive prediction tool to identify pulmonary hypertension in patients with IPF: evolution of the model FORD.
    J Heart Lung Transplant. 2023 Nov 16:S1053-2498(23)02123.
    PubMed     Abstract available
    
    
    October 2023
16. UKITA R, Patel YJ, Kelly Wu W, Francois SA, et al
    Ambulatory Seven-Day Mechanical Circulatory Support in Sheep Model of Pulmonary Hypertension and Right Heart Failure.
    J Heart Lung Transplant. 2023 Oct 29:S1053-2498(23)02081.
    PubMed     Abstract available
    
    
    August 2023
17. YE JR, Hu SY, Lin YH, Huang CH, et al
    Surgery for fibrosing mediastinitis with severe pulmonary hypertension due to pulmonary venous stenosis.
    J Heart Lung Transplant. 2023 Aug 25:S1053-2498(23)02002.
    PubMed     Abstract available
    
    
    
18. PIENN M, Gertz RJ, Gerhardt F, Kroger JR, et al
    CT-derived Lung Vessel Morphology Correlates with Prognostic Markers in Pre-capillary Pulmonary Hypertension.
    J Heart Lung Transplant. 2023 Aug 22:S1053-2498(23)01973.
    PubMed     Abstract available
    
    
    
19. FERNANDES TM, Kim NH, Kerr KM, Auger WR, et al
    Distal vessel pulmonary thromboendarterectomy: Results from a single institution.
    J Heart Lung Transplant. 2023;42:1112-1119.
    PubMed     Abstract available
    
    
    
20. STOLFO D, Barbisan D, Ameri P, Lombardi CM, et al
    Performance of risk stratification scores and role of comorbidities in older vs younger patients with pulmonary arterial hypertension.
    J Heart Lung Transplant. 2023;42:1082-1092.
    PubMed     Abstract available
    
    
    
21. ZHANG J, Kan J, Wei Y, Zhang C, et al
    Treatment effects of pulmonary artery denervation for pulmonary arterial hypertension stratified by REVEAL risk score: Results from PADN-CFDA trial.
    J Heart Lung Transplant. 2023;42:1140-1151.
    PubMed     Abstract available
    
    
    July 2023
22. RAKO ZA, Yogeswaran A, Lakatos BK, Fabian A, et al
    Clinical and functional relevance of right ventricular contraction patterns in pulmonary hypertension.
    J Heart Lung Transplant. 2023 Jul 12:S1053-2498(23)01935.
    PubMed     Abstract available
    
    
    
23. CHAN JCY, Man HSJ, Asghar UM, McRae K, et al
    Impact of sex on outcome after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension.
    J Heart Lung Transplant. 2023 Jul 6:S1053-2498(23)01897.
    PubMed     Abstract available
    
    
    
24. XIE F, Quan R, Zhang G, Tian H, et al
    Characteristics, treatments and survival of pulmonary arterial hypertension associated with congenital heart disease in China: Insights from a national multicenter prospective registry.
    J Heart Lung Transplant. 2023;42:974-984.
    PubMed     Abstract available
    
    
    June 2023
25. WIEDENROTH CB, Guth S
    Response to Huang et al. regarding "Riociguat and balloon pulmonary angioplasty improve prognosis in patients with inoperable chronic thromboembolic pulmonary hypertension".
    J Heart Lung Transplant. 2023 Jun 20:S1053-2498(23)01908.
    PubMed    
    
    
    May 2023
26. ASHWIN REDDY S, Swietlik EM, Robertson L, Michael A, et al
    Natural History of Chronic Thromboembolic Pulmonary Disease with no or mild Pulmonary Hypertension.
    J Heart Lung Transplant. 2023 May 16:S1053-2498(23)01848.
    PubMed     Abstract available
    
    
    April 2023
27. STRUEBER M
    TREATMENT STRATEGIES FOR END-STAGE PULMONARY HYPERTENSION.
    J Heart Lung Transplant. 2023 Apr 4:S1053-2498(23)01814.
    PubMed    
    
    
    March 2023
28. HUANG Y, Zhang QZ, Lv SJ
    Comments and opinions regarding "Riociguat and balloon pulmonary angioplasty improve prognosis in patients with inoperable chronic thromboembolic pulmonary Hypertension".
    J Heart Lung Transplant. 2023 Mar 20:S1053-2498(23)01788.
    PubMed    
    
    
    
29. HADINNAPOLA CM, Southwood M, Hernandez-Sanchez J, Bunclark K, et al
    Angiopoietin 2 and hsCRP are associated with pulmonary hemodynamics and long-term mortality respectively in CTEPH-Results from a prospective discovery and validation biomarker study.
    J Heart Lung Transplant. 2023;42:398-405.
    PubMed     Abstract available
    
    
    
30. FROST AE, Zhao C, Farber HW, Benza R, et al
    Smoking history and pulmonary arterial hypertension: Demographics, onset, and outcomes.
    J Heart Lung Transplant. 2023;42:377-389.
    PubMed     Abstract available
    
    
    January 2023
31. NISHIHARA T, Shimokawahara H, Ogawa A, Naito T, et al
    Comparison of the safety and efficacy of balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension patients with surgically accessible and inaccessible lesions.
    J Heart Lung Transplant. 2023 Jan 19:S1053-2498(23)00007.
    PubMed     Abstract available
    
    
    
32. ROSENKRANZ S, Pausch C, Coghlan JG, Huscher D, et al
    Risk stratification and response to therapy in patients with pulmonary arterial hypertension and comorbidities: A COMPERA analysis.
    J Heart Lung Transplant. 2023;42:102-114.
    PubMed     Abstract available
    
    
    
33. URIEL MH, Clerkin KJ, Takeda K, Naka Y, et al
    Bridging to transplant with HeartMate 3 left ventricular assist devices in the new heart organ allocation system: An individualized approach.
    J Heart Lung Transplant. 2023;42:124-133.
    PubMed     Abstract available
    
    
    December 2022
34. GALLARDO-VARA E, Ntokou A, Dave JM, Jovin DG, et al
    Vascular pathobiology of pulmonary hypertension.
    J Heart Lung Transplant. 2022 Dec 21:S1053-2498(22)02256.
    PubMed     Abstract available
    
    
    
35. RICHTER MJ, Fortuni F, Alenezi F, D'Alto M, et al
    Imaging the right atrium in pulmonary hypertension: A systematic review and meta-analysis.
    J Heart Lung Transplant. 2022 Dec 9:S1053-2498(22)02243.
    PubMed     Abstract available
    
    
    
36. KRIECHBAUM SD, Birmes J, Wiedenroth CB, Adameit MSD, et al
    Exercise MR-proANP unmasks latent right heart failure in CTEPH.
    J Heart Lung Transplant. 2022;41:1819-1830.
    PubMed     Abstract available
    
    
    
37. FAUVEL C, Raitiere O, Boucly A, De Groote P, et al
    Interest of TAPSE/sPAP ratio for noninvasive pulmonary arterial hypertension risk assessment.
    J Heart Lung Transplant. 2022;41:1761-1772.
    PubMed     Abstract available
    
    
    
38. ZI-YANG Y, Hezhi L, Nanshan X, Yin Z, et al
    Model for screening adult congenital heart disease surgery eligibility with echocardiography parameters.
    J Heart Lung Transplant. 2022;41:1831-1838.
    PubMed     Abstract available
    
    
    November 2022
39. HIRSCH K, Nolley S, Ralph DD, Zheng Y, et al
    Circulating markers of inflammation and angiogenesis and clinical outcomes across subtypes of pulmonary arterial hypertension.
    J Heart Lung Transplant. 2022;42:173-82.
    PubMed     Abstract available
    
    
    
40. UKITA R, Stokes JW, Wu WK, Patel YJ, et al
    Large animal preclinical investigation into the optimal extracorporeal life support configuration for pulmonary hypertension and right ventricular failure.
    J Heart Lung Transplant. 2022 Nov 6:S1053-2498(22)02205.
    PubMed     Abstract available
    
    
    
41. BENZA RL, Gomberg-Maitland M, Farber HW, Vizza CD, et al
    Contemporary risk scores predict clinical worsening in pulmonary arterial hypertension - An analysis of FREEDOM-EV.
    J Heart Lung Transplant. 2022;41:1572-1580.
    PubMed     Abstract available
    
    
    October 2022
42. DAHIYA G, Kyvernitakis A, Elhamdani A, Begg A, et al
    Prognostic role of pulmonary hemodynamics before transcatheter aortic valve replacement among patients with severe aortic stenosis.
    J Heart Lung Transplant. 2022 Oct 9:S1053-2498(22)02167.
    PubMed     Abstract available
    
    
    
43. WEATHERALD J, Iqbal H, Mielniczuk L, Syed AR, et al
    Priorities for pulmonary hypertension research: A James Lind Alliance priority setting partnership.
    J Heart Lung Transplant. 2022 Oct 3. pii: S1053-2498(22)02160.
    PubMed     Abstract available
    
    
    September 2022
44. MCGLOTHLIN DP, Granton J, Klepetko W, Beghetti M, et al
    ISHLT consensus statement: Perioperative management of patients with pulmonary hypertension and right heart failure undergoing surgery.
    J Heart Lung Transplant. 2022;41:1135-1194.
    PubMed     Abstract available
    
    
    August 2022
45. GARRY JD, Kolaitis NA, Kronmal R, Thenappan T, et al
    Anticoagulation in pulmonary arterial hypertension - association with mortality, healthcare utilization, and quality of life: The Pulmonary Hypertension Association Registry (PHAR).
    J Heart Lung Transplant. 2022 Aug 28. pii: S1053-2498(22)02085.
    PubMed     Abstract available
    
    
    
46. WIEDENROTH CB, Rolf A, Steinhaus K, Adameit MSD, et al
    Riociguat and balloon pulmonary angioplasty improve prognosis in patients with inoperable chronic thromboembolic pulmonary Hypertension.
    J Heart Lung Transplant. 2022 Aug 23. pii: S1053-2498(22)02077.
    PubMed     Abstract available
    
    
    
47. KIANZAD A, van Wezenbeek J, Celant LR, Oosterveer FPT, et al
    Idiopathic pulmonary arterial hypertension patients with a high H2FPEF-score: Insights from the Amsterdam UMC PAH-cohort.
    J Heart Lung Transplant. 2022;41:1075-1085.
    PubMed     Abstract available
    
    
    
48. BONTA PI, Tramper J, Eberl S, Tepaske R, et al
    Endobronchial blocker use for massive, focal pulmonary hemorrhage during pulmonary endarterectomy for CTEPH.
    J Heart Lung Transplant. 2022;41:1130-1133.
    PubMed     Abstract available
    
    
    July 2022
49. GULATI G, Grandin EW, DeNofrio D, Upshaw JN, et al
    Association between postoperative hemodynamic metrics of pulmonary hypertension and right ventricular dysfunction and clinical outcomes after left ventricular assist device implantation.
    J Heart Lung Transplant. 2022 Jul 23. pii: S1053-2498(22)02029.
    PubMed     Abstract available
    
    
    
50. HALPERN SE, Wright MC, Madsen G, Chow B, et al
    Textbook outcome in lung transplantation: Planned venoarterial extracorporeal membrane oxygenation versus off-pump support for patients without pulmonary hypertension.
    J Heart Lung Transplant. 2022 Jul 21. pii: S1053-2498(22)02041.
    PubMed     Abstract available
    
    
    
51. REDDY SA, Nethercott SL, Teh W, De Bie EM, et al
    Prevalence and clinical significance of conduction disease in patients with idiopathic pulmonary arterial hypertension.
    J Heart Lung Transplant. 2022;41:861-865.
    PubMed     Abstract available
    
    
    
52. HOEPER MM, Pausch C, Olsson KM, Huscher D, et al
    Prognostic value of improvement endpoints in pulmonary arterial hypertension trials: A COMPERA analysis.
    J Heart Lung Transplant. 2022;41:971-981.
    PubMed     Abstract available
    
    
    June 2022
53. VICAIRE H, Pavec JL, Mercier O, Montani D, et al
    Risk stratification in patients with pulmonary arterial hypertension at the time of listing for lung transplantation.
    J Heart Lung Transplant. 2022 Jun 6. pii: S1053-2498(22)01974.
    PubMed     Abstract available
    
    
    
54. BADAGLIACCA R, Rischard F, Giudice FL, Howard L, et al
    Incremental value of cardiopulmonary exercise testing in intermediate-risk pulmonary arterial hypertension.
    J Heart Lung Transplant. 2022;41:780-790.
    PubMed     Abstract available
    
    
    
55. ABDELNOUR-BERCHTOLD E, Donahoe L, McRae K, Asghar U, et al
    Central venoarterial extracorporeal membrane oxygenation as a bridge to recovery after pulmonary endarterectomy in patients with decompensated right heart failure.
    J Heart Lung Transplant. 2022;41:773-779.
    PubMed     Abstract available
    
    
    
56. SUN QW, Sun Z
    Stem cell therapy for pulmonary arterial hypertension: An update.
    J Heart Lung Transplant. 2022;41:692-703.
    PubMed     Abstract available
    
    
    May 2022
57. WIEDENROTH CB, Deissner H, Adameit MSD, Kriechbaum SD, et al
    Complications of balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension: Impact on the outcome.
    J Heart Lung Transplant. 2022 May 20. pii: S1053-2498(22)01944.
    PubMed     Abstract available
    
    
    
58. WEATHERALD J, Thakrar MV, Varughese RA, Kularatne M, et al
    Upfront riociguat and ambrisentan combination therapy for newly diagnosed pulmonary arterial hypertension: A prospective open-label trial.
    J Heart Lung Transplant. 2022;41:563-567.
    PubMed     Abstract available
    
    
    
59. GAIOTTO FA, Bacal F, Steffen SP, Marcondes-Braga FG, et al
    A modified heterotopic heart transplant technique to bridge patients with "fixed" pulmonary hypertension: A case report.
    J Heart Lung Transplant. 2022 May 1. pii: S1053-2498(22)01917.
    PubMed    
    
    
    April 2022
60. VAN WEZENBEEK J, Groeneveldt JA, Llucia-Valldeperas A, van der Bruggen CE, et al
    Interplay of sex hormones and long-term right ventricular adaptation in a Dutch PAH-cohort.
    J Heart Lung Transplant. 2022;41:445-457.
    PubMed     Abstract available
    
    
    March 2022
61. BENZA RL, Boucly A, Farber HW, Frost AE, et al
    Change in REVEAL Lite 2 risk score predicts outcomes in patients with pulmonary arterial hypertension in the PATENT study.
    J Heart Lung Transplant. 2022;41:411-420.
    PubMed     Abstract available
    
    
    February 2022
62. HUMBERT M, Simonneau G, Pittrow D, Delcroix M, et al
    Oral anticoagulants (NOAC and VKA) in chronic thromboembolic pulmonary hypertension.
    J Heart Lung Transplant. 2022 Feb 11. pii: S1053-2498(22)01804.
    PubMed     Abstract available
    
    
    December 2021
63. KREMER N, Rako Z, Douschan P, Gall H, et al
    Unmasking right ventricular-arterial uncoupling during fluid challenge in pulmonary hypertension.
    J Heart Lung Transplant. 2021 Dec 5. pii: S1053-2498(21)02616.
    PubMed     Abstract available
    
    
    November 2021
64. YOGESWARAN A, Tello K, Lund J, Klose H, et al
    Risk assessment in pulmonary hypertension based on routinely measured laboratory parameters.
    J Heart Lung Transplant. 2021 Nov 5. pii: S1053-2498(21)02575.
    PubMed     Abstract available
    
    
    October 2021
65. HANSMANN G, Diekmann F, Chouvarine P, Ius F, et al
    Full recovery of right ventricular systolic function in children undergoing bilateral lung transplantation for severe PAH.
    J Heart Lung Transplant. 2021 Oct 29. pii: S1053-2498(21)02568.
    PubMed     Abstract available
    
    
    
66. ROSEN K, Raanani E, Kogan A, Kenet G, et al
    Chronic thromboembolic pulmonary hypertension in patients with antiphospholipid syndrome: Risk factors and management.
    J Heart Lung Transplant. 2021 Oct 28. pii: S1053-2498(21)02569.
    PubMed     Abstract available
    
    
    
67. HUG KP, Gerry Coghlan J, Cannon J, Taboada D, et al
    Serial right heart catheter assessment between balloon pulmonary angioplasty sessions identify procedural factors that influence response to treatment.
    J Heart Lung Transplant. 2021;40:1223-1234.
    PubMed     Abstract available
    
    
    September 2021
68. BLANQUEZ-NADAL M, Piliero N, Guillien A, Doutreleau S, et al
    Exercise hyperventilation and pulmonary gas exchange in chronic thromboembolic pulmonary hypertension: Effects of balloon pulmonary angioplasty.
    J Heart Lung Transplant. 2021 Sep 22. pii: S1053-2498(21)02504.
    PubMed     Abstract available
    
    
    
69. BOGAERT J, Claessen G, Dresselaers T, Masci PG, et al
    Magnetic resonance relaxometry of the liver - a new imaging biomarker to assess right heart failure in pulmonary hypertension.
    J Heart Lung Transplant. 2021 Sep 16. pii: S1053-2498(21)02492.
    PubMed     Abstract available
    
    
    August 2021
70. FURFARO D, Rosenzweig EB, Shah L, Robbins H, et al
    Lung transplantation disparities based on diagnosis for patients bridging to transplant on extracorporeal membrane oxygenation.
    J Heart Lung Transplant. 2021 Aug 25. pii: S1053-2498(21)02459.
    PubMed     Abstract available
    
    
    
71. DE PERROT M, Gopalan D, Jenkins D, Lang IM, et al
    Evaluation and management of patients with chronic thromboembolic pulmonary hypertension - consensus statement from the ISHLT.
    J Heart Lung Transplant. 2021 Aug 3. pii: S1053-2498(21)02440.
    PubMed     Abstract available
    
    
    July 2021
72. BENZA RL, Ghofrani HA, Grunig E, Hoeper MM, et al
    Effect of riociguat on right ventricular function in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
    J Heart Lung Transplant. 2021 Jul 10. pii: S1053-2498(21)02399.
    PubMed     Abstract available
    
    
    
73. KHIRFAN G, Li M, Wang X, Dweik RA, et al
    Is pulmonary vascular resistance index better than pulmonary vascular resistance in predicting outcomes in pulmonary arterial hypertension?
    J Heart Lung Transplant. 2021;40:614-622.
    PubMed     Abstract available
    
    
    June 2021
74. IRELAND CG, Damico RL, Kolb TM, Mathai SC, et al
    Exercise right ventricular ejection fraction predicts right ventricular contractile reserve.
    J Heart Lung Transplant. 2021;40:504-512.
    PubMed     Abstract available
    
    
    
75. AIRHART S, Badie N, Doyle M, Correa-Jacque P, et al
    Assessing hemodynamic response to submaximal exercise in pulmonary arterial hypertension patients using an implantable hemodynamic monitor.
    J Heart Lung Transplant. 2021;40:430-434.
    PubMed     Abstract available
    
    
    May 2021
76. DAURIAT G, Reynaud-Gaubert M, Cottin V, Lamia B, et al
    Severe pulmonary hypertension associated with chronic obstructive pulmonary disease: A prospective French multicenter cohort.
    J Heart Lung Transplant. 2021 May 11. pii: S1053-2498(21)02307.
    PubMed     Abstract available
    
    
    
77. OLSSON KM, Kamp JC, Hoeper MM
    Pregnancy in PAH: Reality is changing.
    J Heart Lung Transplant. 2021;40:395-396.
    PubMed    
    
    
    April 2021
78. ARTHUR ATAAM J, Mercier O, Lamrani L, Amsallem M, et al
    Retraction notice to ICAM-1 PROMOTES THE ABNORMAL ENDOTHELIAL CELL PHENOTYPE IN CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION.
    J Heart Lung Transplant. 2021;40:318.
    PubMed     Abstract available
    
    
    
79. KIM NH, Hemnes AR, Chakinala MM, Highland KB, et al
    Patient and disease characteristics of the first 500 patients with pulmonary arterial hypertension treated with selexipag in real-world settings from SPHERE.
    J Heart Lung Transplant. 2021;40:279-288.
    PubMed     Abstract available
    
    
    March 2021
80. JEROME LP, Severine F, Olaf M, Pauline P, et al
    Lung and heart-lung transplantation for children with PAH: Dramatic benefits from the implementation of a high-priority allocation program in France.
    J Heart Lung Transplant. 2021 Mar 26. pii: S1053-2498(21)02239.
    PubMed     Abstract available
    
    
    
81. GIRGIS RE, Hoeper MM
    Pulmonary hypertension in fibrosing idiopathic interstitial pneumonia: Uncertainties, challenges and opportunities.
    J Heart Lung Transplant. 2021 Mar 5. pii: S1053-2498(21)02221.
    PubMed     Abstract available
    
    
    
82. TOBITA K, Goda A, Nishida Y, Takeuchi K, et al
    Factors contributing to exercise capacity in chronic thromboembolic pulmonary hypertension with near-normal hemodynamics.
    J Heart Lung Transplant. 2021 Mar 5. pii: S1053-2498(21)02222.
    PubMed     Abstract available
    
    
    
83. WESLEY MILKS M, Sahay S, Benza RL, Farber HW, et al
    Risk assessment in patients with pulmonary arterial hypertension in the era of COVID 19 pandemic and the telehealth revolution: State of the art review.
    J Heart Lung Transplant. 2021;40:172-182.
    PubMed     Abstract available
    
    
    
84. KAMP JC, von Kaisenberg C, Greve S, Winter L, et al
    Pregnancy in pulmonary arterial hypertension: Midterm outcomes of mothers and offspring.
    J Heart Lung Transplant. 2021;40:229-233.
    PubMed    
    
    
    February 2021
85. BRAAMS NJ, van Leeuwen JW, Vonk Noordegraaf A, Nossent EJ, et al
    Right ventricular adaptation to pressure-overload: Differences between chronic thromboembolic pulmonary hypertension and idiopathic pulmonary arterial hypertension.
    J Heart Lung Transplant. 2021 Feb 28. pii: S1053-2498(21)02216.
    PubMed     Abstract available
    
    
    
86. NATHAN SD, Cottin V, Behr J, Hoeper MM, et al
    Impact of lung morphology on clinical outcomes with riociguat in patients with pulmonary hypertension and idiopathic interstitial pneumonia: A post hoc subgroup analysis of the RISE-IIP study.
    J Heart Lung Transplant. 2021 Feb 19. pii: S1053-2498(21)02178.
    PubMed     Abstract available
    
    
    
87. HOEPER MM, Held M
    Response to Badagliacca et al: Multi-dimensional assessment and cluster analysis for idiopathic pulmonary arterial hypertension phenotyping.
    J Heart Lung Transplant. 2021;40:167-168.
    PubMed    
    
    
    
88. BADAGLIACCA R, Papa S, Rischard F
    Multidimensional assessment and cluster analysis for idiopathic pulmonary arterial hypertension phenotyping.
    J Heart Lung Transplant. 2021;40:166-167.
    PubMed    
    
    
    November 2020
89. BESHAY S, Sahay S
    Risk stratification in pulmonary hypertension associated with interstitial lung disease: The holy grail?
    J Heart Lung Transplant. 2020 Nov 27. pii: S1053-2498(20)31850.
    PubMed    
    
    
    
90. JONE PN, Duchateau N, Pan Z, Ivy DD, et al
    Right ventricular area strain from 3-dimensional echocardiography: Mechanistic insight of right ventricular dysfunction in pediatric pulmonary hypertension.
    J Heart Lung Transplant. 2020 Nov 15. pii: S1053-2498(20)31831.
    PubMed     Abstract available
    
    
    October 2020
91. PEREZ-VIZCAINO F
    Lung ACE2 and ADAM17 in pulmonary arterial hypertension: Implications for COVID-19?
    J Heart Lung Transplant. 2020;39:1167-1169.
    PubMed    
    
    
    August 2020
92. RANGANATH NK, Smith DE, Kon ZN
    Awareness of bias in lung transplant registry analyses.
    J Heart Lung Transplant. 2020;39:850-851.
    PubMed    
    
    
    July 2020
93. BADAGLIACCA R, Sciomer S, Petrosillo N
    Endothelin receptor antagonists for pulmonary arterial hypertension and COVID-19: Friend or foe?
    J Heart Lung Transplant. 2020;39:729-730.
    PubMed    
    
    
    June 2020
94. YOGESWARAN A, Tello K, Faber M, Sommer N, et al
    Risk assessment in severe pulmonary hypertension due to interstitial lung disease.
    J Heart Lung Transplant. 2020 Jun 25. pii: S1053-2498(20)31615.
    PubMed     Abstract available
    
    
    
95. ROAN JN, Hsu CH, Fang SY, Chiu MS, et al
    ProT-alpha gene transfer attenuates cardiopulmonary remedying and mortality in a flow-induced pulmonary hypertension rat model.
    J Heart Lung Transplant. 2020 Jun 6. pii: S1053-2498(20)31580.
    PubMed     Abstract available
    
    
    May 2020
96. DESJARDIN JT, Kolaitis NA, Kime N, Kronmal RA, et al
    Age-related differences in hemodynamics and functional status in pulmonary arterial hypertension: Baseline results from the Pulmonary Hypertension Association Registry.
    J Heart Lung Transplant. 2020 May 16. pii: S1053-2498(20)31557.
    PubMed     Abstract available
    
    
    
97. PRESTON IR, Burger CD, Bartolome S, Safdar Z, et al
    Ambrisentan in portopulmonary hypertension: A multicenter, open-label trial.
    J Heart Lung Transplant. 2020;39:464-472.
    PubMed     Abstract available
    
    
    April 2020
98. DAS BB, Jadotte MM, Chan KC
    Use of selexipag in a child with pulmonary hypertension associated with sickle cell disease.
    J Heart Lung Transplant. 2020 Apr 29. pii: S1053-2498(20)31535.
    PubMed    
    
    
    
99. KWON JM, Kim KH, Medina-Inojosa J, Jeon KH, et al
    Artificial intelligence for early prediction of pulmonary hypertension using electrocardiography.
    J Heart Lung Transplant. 2020 Apr 23. pii: S1053-2498(20)31516.
    PubMed     Abstract available
    
    
    
100. CHOMETTE L, Caravita S, Dewachter C, Abramowicz M, et al
     Genetic Profiling of Combined Post-Capillary and Pre-Capillary Pulmonary Hypertension in Left Heart Diseases.
     J Heart Lung Transplant. 2020;39.
     PubMed     Abstract available
     
     
     
101. ROTHAS J, Mahoney E
     Pulmonary Hypertension Support Group: A Year in Review.
     J Heart Lung Transplant. 2020;39.
     PubMed     Abstract available
     
     
     
102. BULLOCK J, Chau P, Wood L, Bock MJ, et al
     Short-Term Outcomes of Infants and Children Receiving Selexipag for Pulmonary Hypertension.
     J Heart Lung Transplant. 2020;39.
     PubMed     Abstract available
     
     
     
103. DJELLAL Y, Vachiery J, Dewachter C, Roussoulieres A, et al
     Role of a Prediction Score of Heart Failure with Left Ventricular Preserved Ejection Fraction in the Differential Diagnosis of Pulmonary Hypertension.
     J Heart Lung Transplant. 2020;39.
     PubMed     Abstract available
     
     
     
104. ALBULUSHI A, Dhar K, Stoller D, Hyden M, et al
     The Effect of Exercise on Endothelin 1 Level in Patients with Pulmonary Hypertension.
     J Heart Lung Transplant. 2020;39.
     PubMed     Abstract available
     
     
     
105. GOLTS EM, Aoki KC, Afshar K, Bigbee JM, et al
     Tricuspid Surgery and Pulmonary Thromboendarterectomy in Patients with Chronic Thromboembolic Pulmonary Hypertension.
     J Heart Lung Transplant. 2020;39.
     PubMed     Abstract available
     
     
     
106. KULARATNE M, Weatherald J, Varughese R, Helmersen D, et al
     Validation of a Nurse Led Triage Algorithm for New Referrals in a Specialized Pulmonary Hypertension Clinic.
     J Heart Lung Transplant. 2020;39.
     PubMed     Abstract available
     
     
     
107. BOULATE D, Pavec JL, Kriens M, Mussot S, et al
     Switching from Heart-Lung to Double Lung Transplantations in Patients with Pre-Capillary Pulmonary Hypertension: A Monocentric Experience.
     J Heart Lung Transplant. 2020;39.
     PubMed     Abstract available
     
     
     
108. KEARNEY K, Bart N, Robson D, Muthiah K, et al
     Haemodynamic Response of Pulmonary Hypertension Secondary to Left Heart Disease with Continuous Flow Left Ventricular Assist Device Therapy (CF-LVADS): Post-Transplant Outcomes.
     J Heart Lung Transplant. 2020;39.
     PubMed     Abstract available
     
     
     
109. DESJARDIN JT, Svetlichnaya Y, Kolaitis NA, Singer JP, et al
     Right Ventricular Outflow Tract Doppler Envelope Notching Predicts Pulmonary Hypertension and Outcomes in Lung Transplant Candidates.
     J Heart Lung Transplant. 2020;39.
     PubMed     Abstract available
     
     
     
110. ARTHUR ATAAM J, Amsallem M, Contrepois K, Guihaire J, et al
     Targeted Angiogenesis Gene Expression Profiling of Patients with Chronic Thromboembolic Pulmonary Hypertension.
     J Heart Lung Transplant. 2020;39.
     PubMed     Abstract available
     
     
     
111. BOTTA L, Murana G, Fiorentino M, Marianna B, et al
     Impact of Severe Pulmonary Hypertension on Right Heart Hemodynamics and Outcomes Following Cardiac Transplantation: A Single Center Experience.
     J Heart Lung Transplant. 2020;39.
     PubMed     Abstract available
     
     
     
112. GABANIC A, Smith SA
     Pulmonary Hypertension Resolves Post Transplantation in Patients Treated with Milrinone or Dobutamine.
     J Heart Lung Transplant. 2020;39.
     PubMed     Abstract available
     
     
     
113. VISHNEVSKY A, Pirlamarla P, Massey HT, Goldhammer J, et al
     Severe Pulmonary Hypertension in the Setting of Complex Structural Heart Disease.
     J Heart Lung Transplant. 2020;39.
     PubMed     Abstract available
     
     
     
114. BENTLEY RF, Barker M, Esfandiari S, Wright SP, et al
     The Relationship between Pulmonary Artery Pulse Pressure and Pulmonary Artery Wedge Pressure during Exercise in Health and in Patients with Suspected Pulmonary Hypertension.
     J Heart Lung Transplant. 2020;39.
     PubMed     Abstract available
     
     
     
115. BART NK, Ambati C, Kearney K, Scheuer S, et al
     Outcomes of Patients with Chronic Thromboembolic Pulmonary Hypertension Risk Stratified by a Dedicated Heart Team to Receive Pulmonary Endarectomy or Balloon Pulmonary Angiogiplasty.
     J Heart Lung Transplant. 2020;39.
     PubMed     Abstract available
     
     
     
116. WANG W, Wilson C, Collum S, Bi W, et al
     Beta Adrenoceptor Ligands for the Treatment of Group 3 Pulmonary Hypertension and Cor Pulmonale: A Novel Therapeutic Target?
     J Heart Lung Transplant. 2020;39.
     PubMed     Abstract available
     
     
     
117. KWON J, Kim K
     Artificial Intelligence for Early Prediction of Pulmonary Hypertension Using Electrocardiography.
     J Heart Lung Transplant. 2020;39.
     PubMed     Abstract available
     
     
     
118. KANWAR MK
     Biomarkers in pulmonary arterial hypertension: Moving closer toward precision medicine?
     J Heart Lung Transplant. 2020;39:287-288.
     PubMed    
     
     
     
119. BADAGLIACCA R, Rischard F, Papa S, Kubba S, et al
     Clinical implications of idiopathic pulmonary arterial hypertension phenotypes defined by cluster analysis.
     J Heart Lung Transplant. 2020;39:310-320.
     PubMed     Abstract available
     
     
     March 2020
120. NASIR BS, Hartwig MG
     Secondary Pulmonary Hypertension; getting down to the nuts and BOLT. Author's reply to Ranganath et al.
     J Heart Lung Transplant. 2020 Mar 5. pii: S1053-2498(20)31424.
     PubMed    
     
     
     February 2020
121. RUOPP NF, Maron BA
     Pulmonary arterial hypertension in the modern era: The intersection of genotype and phenotype.
     J Heart Lung Transplant. 2020;39:113-114.
     PubMed    
     
     
     
122. HIRAIDE T, Kataoka M, Suzuki H, Aimi Y, et al
     Poor outcomes in carriers of the RNF213 variant (p.Arg4810Lys) with pulmonary arterial hypertension.
     J Heart Lung Transplant. 2020;39:103-112.
     PubMed     Abstract available
     
     
     January 2020
123. SHAH M, Saeed O, Shin J, Murthy S, et al
     Predicted heart mass-based size matching among recipients with moderate pulmonary hypertension: Outcomes and sex effect.
     J Heart Lung Transplant. 2020 Jan 31. pii: S1053-2498(20)31357.
     PubMed     Abstract available
     
     
     December 2019
124. BRAAMS NJ, Ruigrok D, Schokker MGM, Padervinskiene L, et al
     Pulmonary vascular imaging characteristics after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension.
     J Heart Lung Transplant. 2019 Dec 5. pii: S1053-2498(19)31791.
     PubMed     Abstract available
     
     
     September 2019
125. ROSENZWEIG EB, Gannon WD, Madahar P, Agerstrand C, et al
     Extracorporeal life support bridge for pulmonary hypertension: A high-volume single-center experience.
     J Heart Lung Transplant. 2019 Sep 12. pii: S1053-2498(19)31671.
     PubMed     Abstract available
     
     
     February 2019
126. SHAFRAN I, Lang IM
     Diffusion capacity of the lung-a disease biomarker linking ventilation and circulation.
     J Heart Lung Transplant. 2019;38:130-132.
     PubMed    
     
     
     
127. AIRHART S, Verlinden N, Badie N, Raina A, et al
     Use of an implantable wireless pulmonary pressure monitor during transition of therapy in pulmonary arterial hypertension.
     J Heart Lung Transplant. 2019;38:227-230.
     PubMed    
     
     
     
128. VACHIERY JL, Galie N, Barbera JA, Frost AE, et al
     Initial combination therapy with ambrisentan+tadalafil on pulmonary arterial hypertensionrelated hospitalization in the AMBITION trial.
     J Heart Lung Transplant. 2019;38:194-202.
     PubMed     Abstract available
     
     
     January 2019
129. FROST A, Janmohamed M, Fritz JS, McConnell JW, et al
     Safety and tolerability of transition from inhaled treprostinil to oral selexipag in pulmonary arterial hypertension: Results from the TRANSIT-1 study.
     J Heart Lung Transplant. 2019;38:43-50.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Pulmonary Hypertension is free of charge.